Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Bergmann

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Therapeutic Advances in Musculoskeletal Disease|November 15, 2019
A cross-sectional investigation into the association between <i>Porphyromonas gingivalis</i> and autoantibodies to citrullinated proteins in a German populationKolade Oluwagbemigun, Tülay Yucel-Lindberg, Thomas Dietrich, et al.
Clinical Lymphoma|July 27, 2002
Fludarabine combination therapy for the treatment of chronic lymphocytic leukemiaBarbara Schmitt, Clemens M Wendtner, Manuela Bergmann, et al.
Scientific Reports|September 22, 2020
Association of familial history of diabetes or myocardial infarction and stroke with risk of cardiovascular diseases in four German cohortsKristin Mühlenbruch, Juliane Menzel, Marcus Dörr, et al.
Haematologica|March 4, 2014
Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trialsValentin Goede, Paula Cramer, Raymonde Busch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
TP53 mutation and survival in chronic lymphocytic leukemiaThorsten Zenz, Barbara Eichhorst, Raymonde Busch, et al.
Blood|December 9, 2010
Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysisBarbara F Eichhorst, Kirsten Fischer, Anna-Maria Fink, et al.
Plos One|September 7, 2013
Progranulin is a novel independent predictor of disease progression and overall survival in chronic lymphocytic leukemiaMaria Göbel, Lewin Eisele, Michael Möllmann, et al.
Public Health Nutrition|March 10, 2011
Feasibility of innovative dietary assessment in epidemiological studies using the approach of combining different assessment instrumentsAnne-Kathrin Illner, Ulrich Harttig, Gianluca Tognon, et al.
Blood|October 13, 2005
Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemiaBarbara F Eichhorst, Raymonde Busch, Georg Hopfinger, et al.
BMC Cancer|June 2, 2018
Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort studyCina J Nattenmüller, Mark Kriegsmann, Disorn Sookthai, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Therapeutic Advances in Musculoskeletal Disease|November 15, 2019
A cross-sectional investigation into the association between <i>Porphyromonas gingivalis</i> and autoantibodies to citrullinated proteins in a German populationKolade Oluwagbemigun, Tülay Yucel-Lindberg, Thomas Dietrich, et al.
Clinical Lymphoma|July 27, 2002
Fludarabine combination therapy for the treatment of chronic lymphocytic leukemiaBarbara Schmitt, Clemens M Wendtner, Manuela Bergmann, et al.
Scientific Reports|September 22, 2020
Association of familial history of diabetes or myocardial infarction and stroke with risk of cardiovascular diseases in four German cohortsKristin Mühlenbruch, Juliane Menzel, Marcus Dörr, et al.
Haematologica|March 4, 2014
Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trialsValentin Goede, Paula Cramer, Raymonde Busch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
TP53 mutation and survival in chronic lymphocytic leukemiaThorsten Zenz, Barbara Eichhorst, Raymonde Busch, et al.
Blood|December 9, 2010
Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysisBarbara F Eichhorst, Kirsten Fischer, Anna-Maria Fink, et al.
Plos One|September 7, 2013
Progranulin is a novel independent predictor of disease progression and overall survival in chronic lymphocytic leukemiaMaria Göbel, Lewin Eisele, Michael Möllmann, et al.
Public Health Nutrition|March 10, 2011
Feasibility of innovative dietary assessment in epidemiological studies using the approach of combining different assessment instrumentsAnne-Kathrin Illner, Ulrich Harttig, Gianluca Tognon, et al.
Blood|October 13, 2005
Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemiaBarbara F Eichhorst, Raymonde Busch, Georg Hopfinger, et al.
BMC Cancer|June 2, 2018
Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort studyCina J Nattenmüller, Mark Kriegsmann, Disorn Sookthai, et al.
Pageof 5